Posters
Presentation Type
Poster
Discipline Track
Community/Public Health
Abstract Type
Program Abstract
Abstract
Diabetic retinopathy (DR) is a leading cause of vision loss globally. The International Diabetes Federation (IDF) estimated the global population with diabetes to be 463 million in 2019 and 700 million in 2045. Retinopathy is a highly specific neurovascular complication of both type 1 and types 2 diabetes, and the prevalence strongly correlates to both the duration of diabetes and the level of glycemic control. Regular follow-up with early detection and treatment of vision-threatening retinopathy enables the prevention of up to 98% of visual loss due to diabetic retinopathy.
Academic/Professional Position
Resident
Mentor/PI Department
Internal Medicine
Recommended Citation
Nadal, Jorge; Soler, Carol; Bartl, Mery; Gomez, Jose; Lopez, Michelle; Alexander, Blesset; Lora, Gabriel; del Real, Azucena; Pesantez, Maria; Saenz, Sergio; and Bernal, Jorge A., "Improvement of diabetic retinopathy screening of diabetic patients seen at the Internal Medicine Clinic" (2023). Research Symposium. 46.
https://scholarworks.utrgv.edu/somrs/2022/posters/46
Improvement of diabetic retinopathy screening of diabetic patients seen at the Internal Medicine Clinic
Diabetic retinopathy (DR) is a leading cause of vision loss globally. The International Diabetes Federation (IDF) estimated the global population with diabetes to be 463 million in 2019 and 700 million in 2045. Retinopathy is a highly specific neurovascular complication of both type 1 and types 2 diabetes, and the prevalence strongly correlates to both the duration of diabetes and the level of glycemic control. Regular follow-up with early detection and treatment of vision-threatening retinopathy enables the prevention of up to 98% of visual loss due to diabetic retinopathy.